Outcomes of tacrolimus therapy in adults with refractory membranous nephrotic syndrome: a prospective, multicenter clinical trial.

@article{Chen2013OutcomesOT,
  title={Outcomes of tacrolimus therapy in adults with refractory membranous nephrotic syndrome: a prospective, multicenter clinical trial.},
  author={Wei Chen and Qinghua Liu and Yunhua Liao and Zhenhua Yang and Jian Jiun Chen and Junzhou Fu and Jinli Zhang and Yaozhong Kong and P. L. Fu and Tanqi Q Lou and Zhengrong Liu and Yulian Ji and Zhibin Li and Xue-qing Yu},
  journal={The American journal of the medical sciences},
  year={2013},
  volume={345 2},
  pages={81-7}
}
INTRODUCTION The treatment of adult refractory idiopathic membranous nephropathy with steroid and other immunosuppressant-resistant nephrotic syndrome can be a significant challenge. The authors investigated the efficacy and safety of tacrolimus (TAC) as a promising regimen. METHODS A prospective, multicenter trial was conducted in 9 nephrology centers from 2006 to 2008. Fourteen patients were enrolled. In conjunction with prednisone, TAC was started at 0.05 mg/kg/d, titrated to achieve a… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS
7 Citations
43 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 43 references

Similar Papers

Loading similar papers…